Heart Failure Clinical Trials

Find Heart Failure Clinical Trials Near You

IEEM-Heat and Heart Failure

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

We will test the hypothesis that increasing skin wetness, and thus evaporative cooling, will attenuate the increase in core body temperature and accompanying cardiac stress during heat wave conditions in individuals with congestive heart failure. Secondly, we propose that wearing a water-saturated T-shirt will also be beneficial to attenuate the increase in core body temperature and accompanying cardiac stress during heat wave conditions in individuals with congestive heart failure. To accomplish these objectives, individuals with congestive heart failure and otherwise healthy control individuals will be exposed to the simulated heat wave condition (hot and dry) with the following cooling modalities: A) control trial (no limb immersion or skin wetting), B) skin wetting only trial, and C) water-saturated T-shirt trial in a randomized crossover fashion. Thermoregulatory and cardiovascular responses will be evaluated throughout these simulated heat wave exposures. Primary outcomes variables will be skin and core temperatures, while secondary variables will include measures of cardiovascular stress, myocardial perfusion, heart rate, and echo-based measures of cardiac function.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Healthy Volunteers: t
View:

• Participants must be free of any significant underlying medical problems based upon a detailed medical history and physical exam, and normal resting electrocardiogram. Participants must be 45+ years.

⁃ \- The participant must have a diagnosis of congestive heart failure (e.g., heart failure with reduced ejection fraction), with the severity categorized as New York Heart Association (NYHA) class II or III. Participants must be 45+ years.

Locations
United States
Texas
Institute for Exercise and Environmental Medicine - Texas Health Presbyterian Hospital Dallas
RECRUITING
Dallas
Contact Information
Primary
Craig Crandall, PhD
craigcrandall@texashealth.org
214-345-4623
Backup
Erin Harper, BS
erinharper2@texashealth.org
214-345-4737
Time Frame
Start Date: 2025-10-01
Estimated Completion Date: 2030-07-01
Participants
Target number of participants: 88
Treatments
Active_comparator: Individuals with Congestive Heart Failure (CHF)
Active_comparator: Individuals without Congestive Heart Failure (Control)
Related Therapeutic Areas
Sponsors
Leads: University of Texas Southwestern Medical Center

This content was sourced from clinicaltrials.gov